Pivot Bio IPO
Pivot Bio is an agricultural technology company that develops nitrogen-producing microbes as an alternative to synthetic fertilizers. The company's microbial technology helps farmers reduce fertilizer costs while maintaining crop yields and reducing environmental impact. Investors see IPO potential in Pivot Bio due to growing demand for sustainable agriculture solutions and the company's innovative approach to crop nutrition.
Key Facts
| Industry | Agricultural Biotechnology |
| Founded | 2010 |
| Headquarters | Berkeley, CA |
| Employees | ~400 |
| Website | pivotbio.com |
| Funding | Series D raised $430M. Total raised: $644M |
About Pivot Bio
Pivot Bio develops nitrogen-producing microbes that can reduce farmers' dependence on synthetic fertilizers. The company's flagship products use engineered bacteria that colonize plant roots and fix atmospheric nitrogen, providing a biological alternative to traditional nitrogen fertilizers that can reduce input costs and environmental impact.
The company has commercialized products for corn and is expanding to other crops, with its PROVEN technology showing significant adoption among U.S. farmers. Pivot Bio's approach addresses major agricultural challenges including fertilizer price volatility, supply chain disruptions, and environmental concerns around nitrogen runoff. The company represents a significant shift toward biological solutions in agriculture, backed by substantial venture funding and partnerships with major agricultural distributors.
IPO Status
Pivot Bio has not announced any IPO plans. The company has raised significant venture funding, including a $430 million Series D round in 2021 that valued the company at over $2 billion, achieving unicorn status in the agricultural technology sector. Despite strong funding milestones and growing adoption of its microbial nitrogen technology among farmers, Pivot Bio has not indicated any timeline for going public. The agricultural technology market has seen varied IPO performance, and the company may be focusing on scaling its biological manufacturing capabilities and expanding market penetration before considering public markets. The sustainable agriculture sector continues to attract significant investor interest driven by environmental and economic benefits.
Competitors
Frequently Asked Questions
Does Pivot Bio have a stock?
No, Pivot Bio has not had an IPO. The company is privately held despite achieving unicorn valuation status.
When is the Pivot Bio IPO date?
Pivot Bio has not announced an IPO date or timeline. No confirmed details are available about when the company might consider going public.
How can I buy Pivot Bio stock?
Pivot Bio stock is not available for public purchase. As a private company, shares are only accessible to private investors and employees.
Stay Updated on the Pivot Bio IPO
Get real-time alerts when Pivot Bio files for an IPO, prices shares, or begins trading.
Get IPO Alerts